Our patented technology represents a significant breakthrough in intra-cellular gene regulation; and our topical preparations demonstrate a high safety/efficacy profile. Our novel cell-free production capability of clinical grade DNA represents a major advance in the field and has positioned CytoGenix to become a leader in this cutting edge area of therapeutic development.